NO135785B - - Google Patents
Download PDFInfo
- Publication number
- NO135785B NO135785B NO4082/71A NO408271A NO135785B NO 135785 B NO135785 B NO 135785B NO 4082/71 A NO4082/71 A NO 4082/71A NO 408271 A NO408271 A NO 408271A NO 135785 B NO135785 B NO 135785B
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- isoindoline
- methyl
- oxo
- general formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 69
- 229910052739 hydrogen Inorganic materials 0.000 claims description 21
- 239000001257 hydrogen Substances 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 13
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 claims description 12
- 150000002431 hydrogen Chemical group 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 7
- WQBXDMCOVLBREU-UHFFFAOYSA-N 3h-2-benzofuran-1-thione Chemical compound C1=CC=C2C(=S)OCC2=C1 WQBXDMCOVLBREU-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical class C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- -1 ampoules Substances 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 24
- 238000010992 reflux Methods 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 238000002425 crystallisation Methods 0.000 description 11
- 230000008025 crystallization Effects 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 7
- 125000005219 aminonitrile group Chemical group 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- RZSVLKAIDMAXLB-UHFFFAOYSA-N 2-(4-aminophenyl)propanenitrile Chemical compound N#CC(C)C1=CC=C(N)C=C1 RZSVLKAIDMAXLB-UHFFFAOYSA-N 0.000 description 6
- QGXNHCXKWFNKCG-UHFFFAOYSA-N 2-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC=C1C#N QGXNHCXKWFNKCG-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 5
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- YAVXGZPCODWPJL-UHFFFAOYSA-N 2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1N1C(=O)C2=CC=CC=C2C1 YAVXGZPCODWPJL-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- YOOKIEIXJFYJSO-UHFFFAOYSA-N ethyl 2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]acetate Chemical compound C1=CC(CC(=O)OCC)=CC=C1N1C(=O)C2=CC=CC=C2C1 YOOKIEIXJFYJSO-UHFFFAOYSA-N 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 229940049953 phenylacetate Drugs 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- WOMVICAMAQURRN-UHFFFAOYSA-N 2-(4-aminophenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(N)C=C1 WOMVICAMAQURRN-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- MWBVNWYNXULIDI-UHFFFAOYSA-N ethyl 2-(4-aminophenyl)propanoate Chemical compound CCOC(=O)C(C)C1=CC=C(N)C=C1 MWBVNWYNXULIDI-UHFFFAOYSA-N 0.000 description 3
- CJORTZHHUZARCF-UHFFFAOYSA-N ethyl 2-[4-(1,3-dioxoisoindol-2-yl)phenyl]acetate Chemical compound C1=CC(CC(=O)OCC)=CC=C1N1C(=O)C2=CC=CC=C2C1=O CJORTZHHUZARCF-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- MRVPEWNZGHSFAC-UHFFFAOYSA-N 2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]pentanoic acid Chemical compound C1=CC(C(C(O)=O)CCC)=CC=C1N1C(=O)C2=CC=CC=C2C1 MRVPEWNZGHSFAC-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- AYDXAULLCROVIT-UHFFFAOYSA-N indobufen Chemical compound C1=CC(C(C(O)=O)CC)=CC=C1N1C(=O)C2=CC=CC=C2C1 AYDXAULLCROVIT-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009291 secondary effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- AKVCHYGHEAZANX-UHFFFAOYSA-N 1-phenyl-2,3-dihydro-1h-isoindole Chemical compound C12=CC=CC=C2CNC1C1=CC=CC=C1 AKVCHYGHEAZANX-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- KBGDCMWERIPOGL-UHFFFAOYSA-N 2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]hexanoic acid Chemical compound C1=CC(C(C(O)=O)CCCC)=CC=C1N1C(=O)C2=CC=CC=C2C1 KBGDCMWERIPOGL-UHFFFAOYSA-N 0.000 description 1
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- ZGSDJMADBJCNPN-UHFFFAOYSA-N [S-][NH3+] Chemical compound [S-][NH3+] ZGSDJMADBJCNPN-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001887 cortisones Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- MNMGJJXEOOBVRH-UHFFFAOYSA-N ethyl 2-[4-(1,3-dioxoisoindol-2-yl)phenyl]hexanoate Chemical compound C1=CC(C(C(=O)OCC)CCCC)=CC=C1N1C(=O)C2=CC=CC=C2C1=O MNMGJJXEOOBVRH-UHFFFAOYSA-N 0.000 description 1
- JTLRDZGNCISUBS-UHFFFAOYSA-N ethyl 2-[4-(1,3-dioxoisoindol-2-yl)phenyl]pentanoate Chemical compound C1=CC(C(C(=O)OCC)CCC)=CC=C1N1C(=O)C2=CC=CC=C2C1=O JTLRDZGNCISUBS-UHFFFAOYSA-N 0.000 description 1
- MCMRQPMHFLDMSK-UHFFFAOYSA-N ethyl 2-[4-(3-imino-1h-isoindol-2-yl)phenyl]acetate Chemical compound C1=CC(CC(=O)OCC)=CC=C1N1C(=N)C2=CC=CC=C2C1 MCMRQPMHFLDMSK-UHFFFAOYSA-N 0.000 description 1
- HVGSKNDLBVBCTQ-UHFFFAOYSA-N ethyl 2-[4-(3-imino-1h-isoindol-2-yl)phenyl]butanoate Chemical compound C1=CC(C(CC)C(=O)OCC)=CC=C1N1C(=N)C2=CC=CC=C2C1 HVGSKNDLBVBCTQ-UHFFFAOYSA-N 0.000 description 1
- LPWNJGMVZBLMCW-UHFFFAOYSA-N ethyl 2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]butanoate Chemical compound C1=CC(C(CC)C(=O)OCC)=CC=C1N1C(=O)C2=CC=CC=C2C1 LPWNJGMVZBLMCW-UHFFFAOYSA-N 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- RJMIEHBSYVWVIN-UHFFFAOYSA-N indoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FTIZYGAOMCFUIA-UHFFFAOYSA-N methyl 2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]acetate Chemical compound C1=CC(CC(=O)OC)=CC=C1N1C(=O)C2=CC=CC=C2C1 FTIZYGAOMCFUIA-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 125000005543 phthalimide group Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT3133470 | 1970-11-05 | ||
| IT3151470 | 1970-11-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO135785B true NO135785B (fi) | 1977-02-21 |
| NO135785C NO135785C (fi) | 1977-06-01 |
Family
ID=26328923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO4082/71A NO135785C (fi) | 1970-11-05 | 1971-11-04 |
Country Status (18)
| Country | Link |
|---|---|
| JP (6) | JPS5111627B1 (fi) |
| AT (1) | AT313894B (fi) |
| BE (1) | BE774985A (fi) |
| CA (1) | CA978973A (fi) |
| CH (4) | CH559176A5 (fi) |
| DD (1) | DD95379A5 (fi) |
| DK (1) | DK154761C (fi) |
| ES (1) | ES396473A1 (fi) |
| FI (1) | FI54294C (fi) |
| FR (1) | FR2112480A1 (fi) |
| HU (1) | HU164391B (fi) |
| IE (1) | IE35767B1 (fi) |
| IL (1) | IL38023A (fi) |
| MY (1) | MY7400288A (fi) |
| NL (1) | NL170283C (fi) |
| NO (1) | NO135785C (fi) |
| SE (1) | SE374917B (fi) |
| YU (1) | YU34984B (fi) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2154525A1 (de) * | 1970-11-05 | 1972-06-15 | Carlo Erba S.P.A., Mailand (Italien) | Isoindolinderivate und Verfahren zu ihrer Herstellung |
| DE2755345A1 (de) * | 1977-04-05 | 1978-10-19 | Grelan Pharmaceutical Co | 2-oxo-phenylbuttersaeure-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate |
| JPS53145735U (fi) * | 1977-04-23 | 1978-11-16 | ||
| JPS545333U (fi) * | 1977-06-15 | 1979-01-13 | ||
| JPS5416115U (fi) * | 1977-07-01 | 1979-02-01 | ||
| JPS5424235U (fi) * | 1977-07-20 | 1979-02-17 | ||
| JPS6210796Y2 (fi) * | 1979-06-01 | 1987-03-13 | ||
| US5480362A (en) * | 1992-09-03 | 1996-01-02 | Honda Giken Kogyo Kabushiki Kaisha | Double planetary carrier |
| CN1302881C (zh) * | 2004-12-10 | 2007-03-07 | 华东理工大学 | 超高压超临界流体微射流技术制备超细粉体的方法及装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2034240C2 (de) * | 1968-03-27 | 1982-12-02 | CIBA-GEIGY AG, 4002 Basel | Isoindolinderivate, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung |
| JPS5035076A (fi) * | 1973-08-01 | 1975-04-03 |
-
1971
- 1971-10-22 FI FI2988/71A patent/FI54294C/fi active
- 1971-10-25 IE IE1342/71A patent/IE35767B1/xx unknown
- 1971-10-27 IL IL38023A patent/IL38023A/en unknown
- 1971-10-28 ES ES396473A patent/ES396473A1/es not_active Expired
- 1971-10-29 YU YU2756/71A patent/YU34984B/xx unknown
- 1971-11-04 HU HUCA317A patent/HU164391B/hu unknown
- 1971-11-04 CA CA126,830A patent/CA978973A/en not_active Expired
- 1971-11-04 AT AT952271A patent/AT313894B/de not_active IP Right Cessation
- 1971-11-04 NO NO4082/71A patent/NO135785C/no unknown
- 1971-11-04 SE SE7114082A patent/SE374917B/xx unknown
- 1971-11-04 DD DD158754A patent/DD95379A5/xx unknown
- 1971-11-05 BE BE774985A patent/BE774985A/xx not_active IP Right Cessation
- 1971-11-05 JP JP46088188A patent/JPS5111627B1/ja active Pending
- 1971-11-05 FR FR7139823A patent/FR2112480A1/fr active Granted
- 1971-11-05 NL NLAANVRAGE7115288,A patent/NL170283C/xx not_active IP Right Cessation
- 1971-11-05 CH CH1247774A patent/CH559176A5/xx not_active IP Right Cessation
- 1971-11-05 CH CH1247674A patent/CH559175A5/xx not_active IP Right Cessation
- 1971-11-05 CH CH1247574A patent/CH559174A5/xx not_active IP Right Cessation
- 1971-11-05 CH CH1615771A patent/CH558353A/xx not_active IP Right Cessation
- 1971-11-05 DK DK541671A patent/DK154761C/da not_active IP Right Cessation
-
1974
- 1974-12-30 MY MY288/74A patent/MY7400288A/xx unknown
-
1975
- 1975-10-24 JP JP50128260A patent/JPS5168563A/ja active Granted
-
1976
- 1976-04-02 JP JP51037028A patent/JPS5217463A/ja active Pending
- 1976-04-02 JP JP51037026A patent/JPS5231065A/ja active Granted
- 1976-04-02 JP JP51037027A patent/JPS5231066A/ja active Granted
-
1978
- 1978-09-14 JP JP53113483A patent/JPS6019748B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4327222A (en) | 3,4-Diarylisoxazol-5-acetic acids and process for making same | |
| NO142441B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater | |
| JPS582935B2 (ja) | ５↓−アロイルピロ−ル誘導体の製造法 | |
| US3810906A (en) | N1-heteroacylated phenylhydrazines | |
| JPH02346B2 (fi) | ||
| NO135785B (fi) | ||
| JPH0742290B2 (ja) | １，２−ジヒドロ−３Ｈ−ピロロ〔１，２−α〕ピロール−１−カルボン酸エステルの５位のアロイル化方法 | |
| US4104285A (en) | Taurine and glycine derivatives | |
| EP0139584A2 (fr) | Dérivés d'imidazoline, leur préparation et leur application en thérapeutique | |
| US3631177A (en) | 3-phenacyl-2-oxoindolines | |
| US4118504A (en) | Isoindoline derivatives for treating pain | |
| NO130549B (fi) | ||
| US3519592A (en) | Indole compounds | |
| JPH03141244A (ja) | アラルキルアミン誘導体 | |
| SU448644A3 (ru) | Способ получени изоиндолиновых производных | |
| US2906757A (en) | Their preparation | |
| JPS6031823B2 (ja) | カルバゾ−ル誘導体の製造方法 | |
| US4568690A (en) | 1-Methyl-5-p-methylbenzoylpyrrole-2-acetamidoacetanilides with antiinflammatory, analgesic, antipyretic and anti-platelet aggregant activity | |
| US3592813A (en) | 3-phenyl-9h-pyridazino(3,4-b)indoles | |
| JP2020528067A (ja) | ステロイド系誘導体ｆｘｒアゴニストの結晶又は非晶質、その製造方法及び使用 | |
| US4189607A (en) | Anilionotropone derivatives | |
| US3159648A (en) | Process to prepare i | |
| US3598861A (en) | 2-(5'-phenyl-m-terphenyl - 4 - yloxy) lower aliphatic monocarbocyclic acids and esters thereof | |
| US2486796A (en) | Esters of 1-alkyl-4-hydroxyphenylpiperidyl-4-ketones | |
| US3631178A (en) | 2-oxoindolines |